99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study.

MLA

Chianelli, M., et al. “99mTc-Interleukin-2 Scintigraphy in Normal Subjects and in Patients with Autoimmune Thyroid Diseases: A Feasibility Study.” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 12, Dec. 2008, pp. 2286–93. EBSCOhost, https://doi.org/10.1007/s00259-008-0837-7.

APA

Chianelli, M., Mather, S. J., Grossman, A., Sobnak, R., Fritzberg, A., Britton, K. E., & Signore, A. (2008). 99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study. European Journal of Nuclear Medicine and Molecular Imaging, 35(12), 2286–2293. https://doi.org/10.1007/s00259-008-0837-7

Chicago

Chianelli, M, S J Mather, A Grossman, R Sobnak, A Fritzberg, K E Britton, and A Signore. 2008. “99mTc-Interleukin-2 Scintigraphy in Normal Subjects and in Patients with Autoimmune Thyroid Diseases: A Feasibility Study.” European Journal of Nuclear Medicine and Molecular Imaging 35 (12): 2286–93. doi:10.1007/s00259-008-0837-7.